ClinicalTrials.gov
ClinicalTrials.gov Menu

A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01028495
Recruitment Status : Completed
First Posted : December 9, 2009
Last Update Posted : August 29, 2012
Sponsor:
Information provided by (Responsible Party):
Rexahn Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2012
  Actual Study Completion Date : August 2012
Publications of Results:
Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 3564

Other Publications: